Jupiter Neurosciences, Inc. (JUNS)
Nasdaq: JUNS · Pharmaceutical Preparations · Jupiter, FL · filing with the SEC since 2016
Who runs Jupiter Neurosciences, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Rosen Christer
CEO and Chairman. First filing Nov 2024, latest Jun 4, 2026, 2 filings in all.
Officers reporting now
5
of 11 people with a filing in the last fifteen months
Directors reporting now
6
11 people on the record since 2024
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Hayward Marshall A. | Chief Scientific Officer | Nov 2024 | Jul 13, 2026 | none |
| Rosen Alexander Gustaf Erik | Chief Administrative Officer | Nov 2024 | Jul 13, 2026 | none |
| Rosen Christer | CEO and Chairman | Nov 2024 | Jun 4, 2026 | none |
| Silva Alison D. | President and COO | Nov 2024 | Jun 4, 2026 | none |
| Elmasri Saleem | Chief Financial Officer | Nov 2024 | Jun 4, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Cutler Andrew Jon | director | Jul 2026 | Aug 5, 2026 | none |
| Hemmerly Nicholas H. | director | Nov 2024 | Jul 13, 2026 | none |
| Kampf Julie B. | director | Nov 2024 | Jul 13, 2026 | none |
| Weis Holger | director | Nov 2024 | Jul 13, 2026 | none |
| Philipson Tomas Jan | director | Jul 2026 | Jul 1, 2026 | none |
| Brady Allison W | director | Nov 2024 | Jun 5, 2026 | none |
Earlier names on the record1, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.